Literature DB >> 31091218

Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease.

Bairbre A McNicholas, Yoshida Kotaro1, William Martin2, Ayush Sharma3, Patrick S Kamath3, Marie E Edwards2, Walter K Kremers4, Suresh T Chari3, Vicente E Torres2, Peter C Harris2, Naoki Takahashi1, Marie C Hogan2.   

Abstract

OBJECTIVES: Pancreatic lesions in autosomal dominant polycystic kidney disease (ADPKD) are primarily cysts. They are increasingly recognized, with isolated reports of intraductal papillary mucinous neoplasia (IPMN).
METHODS: Retrospective study to determine prevalence, number, size, and location of pancreatic abnormalities using abdominal magnetic resonance imaging (MRI) of genotyped ADPKD patients (seen February 1998 to October 2013) and compared with age- and sex-matched non-ADPKD controls. We evaluated presentation, investigation, and management of all IPMNs among individuals with ADPKD (January 1997 to December 2016).
RESULTS: Abdominal MRIs were examined for 271 genotyped ADPKD patients. A pancreatic cyst lesion (PCL) was detected in 52 patients (19%; 95% confidence interval, 15%-23%). Thirty-seven (71%) had a solitary PCL; 15 (28%) had multiple. Pancreatic cyst lesion prevalence did not differ by genotype. Intraductal papillary mucinous neoplasia was detected in 1% of ADPKD cases. Among 12 IPMN patients (7 branch duct; 5 main duct or mixed type) monitored for about 140 months, 2 with main duct IPMNs required Whipple resection, and 1 patient died of complications from small-bowel obstruction after declining surgical intervention.
CONCLUSIONS: With MRI, PCLs were detected in 19% and IPMNs in 1% of 271 ADPKD patients with proven mutations, without difference across genotypes. Pancreatic cyst lesions were asymptomatic and remained stable in size.

Entities:  

Mesh:

Year:  2019        PMID: 31091218      PMCID: PMC6521861          DOI: 10.1097/MPA.0000000000001306

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  39 in total

Review 1.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

2.  Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease.

Authors:  R Torra; C Nicolau; C Badenas; S Navarro; L Pérez; X Estivill; A Darnell
Journal:  Clin Nephrol       Date:  1997-01       Impact factor: 0.975

3.  Intraductal papillary mucinous tumor of the pancreas associated with autosomal dominant polycystic kidney disease.

Authors:  Hiroshi Naitoh; Hisanori Shoji; Isao Ishikawa; Reina Watanabe; Yuichi Furuta; Shigeru Tomozawa; Hiroaki Igarashi; Sachiko Shinozaki; Hideyuki Katsura; Ryoichi Onozato; Masayoshi Kudoh
Journal:  J Gastrointest Surg       Date:  2005 Jul-Aug       Impact factor: 3.452

4.  Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.

Authors:  Won Jae Yoon; Ji Kon Ryu; Jun Kyu Lee; Sang Myung Woo; Sang Hyub Lee; Joo Kyung Park; Yong-Tae Kim; Yong Bum Yoon
Journal:  Ann Surg Oncol       Date:  2008-09-11       Impact factor: 5.344

5.  Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.

Authors:  Stefano Crippa; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Giovanni Marchegiani; Vinciane Rebours; Philippe Levy; Stefano Partelli; Shadeah L Suleiman; Peter A Banks; Nazir Ahmed; Suresh T Chari; Carlos Fernández-Del Castillo; Massimo Falconi
Journal:  Gut       Date:  2016-01-07       Impact factor: 23.059

6.  Autosomal-dominant polycystic kidney disease: high prevalence of graft loss for death-related malignancies and cardiovascular risk factors.

Authors:  P Errasti; J Manrique; J Lavilla; E Rossich; A Hernandez; D Pujante; A Ndarabu; N García; A Purroy
Journal:  Transplant Proc       Date:  2003-08       Impact factor: 1.066

7.  Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.

Authors:  Edwin M Spithoven; Anneke Kramer; Esther Meijer; Bjarne Orskov; Christoph Wanner; Jose M Abad; Nuria Aresté; Ramón Alonso de la Torre; Fergus Caskey; Cécile Couchoud; Patrik Finne; James Heaf; Andries Hoitsma; Johan de Meester; Julio Pascual; Maurizio Postorino; Pietro Ravani; Oscar Zurriaga; Kitty J Jager; Ron T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

Review 8.  Management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masanori Sugiyama; Yutaka Suzuki; Nobutsugu Abe; Toshiyuki Mori; Yutaka Atomi
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

9.  Prediction of malignancy in cystic neoplasms of the pancreas: a population-based cohort study.

Authors:  Bechien U Wu; Kartik Sampath; Christopher E Berberian; Karl K Kwok; Brian S Lim; Kevin T Kao; Andrew Q Giap; Anne E Kosco; Yasir M Akmal; Andrew L Difronzo; Wei Yu; Eunis W Ngor
Journal:  Am J Gastroenterol       Date:  2013-10-01       Impact factor: 10.864

10.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

View more
  1 in total

1.  Adult Inactivation of the Recessive Polycystic Kidney Disease Gene Causes Polycystic Liver Disease.

Authors:  Whitney Besse; Charlotte Roosendaal; Luigi Tuccillo; Sounak Ghosh Roy; Anna-Rachel Gallagher; Stefan Somlo
Journal:  Kidney360       Date:  2020-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.